Deferred Tax Assets, Valuation Allowance of Ernexa Therapeutics Inc. from 31 Dec 2014 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Ernexa Therapeutics Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2014 to 31 Dec 2024.
  • Ernexa Therapeutics Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $26,023,000, a 42% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Ernexa Therapeutics Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $26,023,000 +$7,721,000 +42% 31 Dec 2024 10-K 12 Mar 2025 2024 FY
Q4 2023 $18,302,000 +$2,145,000 +13% 31 Dec 2023 10-K 12 Mar 2025 2024 FY
Q4 2022 $16,157,000 +$8,690,000 +116% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q4 2021 $7,467,000 +$6,720,000 +900% 31 Dec 2021 10-K 20 Mar 2023 2022 FY
Q4 2020 $747,000 -$15,471,000 -95% 31 Dec 2020 10-K/A 01 Jul 2022 2021 FY
Q4 2019 $16,218,000 -$931,000 -5.4% 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q4 2018 $17,149,000 +$809,000 +5% 31 Dec 2018 10-K 19 Mar 2020 2019 FY
Q4 2017 $16,340,000 -$8,540,000 -34% 31 Dec 2017 10-K 22 Mar 2019 2018 FY
Q4 2016 $24,880,000 +$439,000 +1.8% 31 Dec 2016 10-K 09 Mar 2018 2017 FY
Q4 2015 $24,441,000 +$873,000 +3.7% 31 Dec 2015 10-K 09 Mar 2017 2016 FY
Q4 2014 $23,568,000 31 Dec 2014 10-K 15 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.